Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways

Toxicology and Applied Pharmacology

Volumn 159, Issue 1, 1999, Pages 65-75

  Barchowsky, Aaron ^a   Roussel, Robert R ^a   Klei, Linda R ^a   James, Philip E ^a   Ganju, Neema ^a   Smith, Karol R ^a   Dudek, Edward J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Arsenic; Arsenite; Endothelial cells; Erk; Hydrogen peroxide; Mitogen activated kinase; NF B; Oxidant stress; p38; Src kinase

Indexed keywords

ARSENIC TRIOXIDE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZING AGENT; PROTEIN KINASE; SUPEROXIDE; TYROSINE;

ANIMAL CELL; AORTA; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; NONHUMAN; PHENOTYPE; PROTEIN PHOSPHORYLATION; STRESS; SWINE;

EID: 0033566942     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8723     Document Type: Article

References (51)

1. Anderson M. T., Staal F. J. T., Gitler C., Herzenberg L. A. Separation of oxidant-initiated and redox-regulated steps in the NF-kB signal transduction pathway. Proc. Natl. Acad. Sci. USA. 91:1994;11527-11531.
2. Auble D. T., Brinckerhoff C. E. The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. Biochemistry. 30:1991;4629-4635.
3. Barchowsky A., Dudek E. J., Treadwell M. D., Wetterhahn K. E. Arsenic Induces Oxidant Stress and NF-KappaB Activation In Cultured Aortic Endothelial Cells. Free Radic. Biol. Med. 21:1996;783-790.
4. Barchowsky A., Lannon B. M., Elmore L. C., Treadwell M. D. Increased focal adhesion kinase- and urokinase-type plasminogen activator receptor-associated cell signaling in endothelial cells exposed to asbestos. Environ. Health Perspect. 105:1997;1131-1137.
5. Barchowsky A., Munro S. R., Morana S. J., Vincenti M. P., Treadwell M. Oxidant-sensitive and phosphorylation-dependent activation of NF-kappaB and AP-1 in endothelial cells. Am. J. Physiol. 269:1995;L829-L836.
6. Barchowsky A., Tabrizi K., Kent R. S., Whorton A. R. Inhibition of prostaglandin synthesis after metabolism of menadione by cultured porcine endothelial cells. J. Clin. Invest. 83:1989;1153-1159.
7. Bouchie J. L., Hansen H., Feener E. P. Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen system. Arterioscler. Thromb. Vasc. Biol. 18:1998;1771-1779.
8. Carmignani M., Boscolo P., Castellino N. Metabolic fate and cardiovascular effects of arsenic in rats and rabbits chronically exposed to trivalent and pentavalent arsenic. Arch. Toxicol. Suppl. 8:1985;452-455.
9. Cavigelli M., Li W. W., Lin A., Su B., Yoshioka K., Karin M. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J. 15:1996;6269-6279.
10. Chen C. J., Chiou H. Y., Chiang M. H., Lin L. J., Tai T. Y. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler. Thromb. Vasc. Biol. 16:1996;504-510.
11. Chen W., Martindale J. L., Holbrook N. J., Liu Y. Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc. Mol. Cell. Biol. 18:1998;5178-5188.
12. Chiou H. Y., Huang W. I., Su C. L., Chang S. F., Hsu Y. H., Chen C. J. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke. 28:1997;1717-1723.
13. Defilippi P., Retta S. F., Olivo C., Palmieri M., Venturino M., Silengo L., Tarone G. p125FAK tyrosine phosphorylation and focal adhesion assembly: Studies with phosphotyrosine phosphatase inhibitors. Exp. Cell Res. 221:1995;141-152.
14. Deneke S. M. Induction of cystine transport in bovine pulmonary artery endothelial cells by sodium arsenite. Biochim. Biophys. Acta. 1109:1992;127-131.
15. Doza Y. N., Hall-Jackson C. A., Cohen P. Arsenite blocks growth factor induced activation of the MAP kinase cascade, upstream of Ras and downstream of Grb2-Sos. Oncogene. 17:1998;19-24.
16. Engel R. R., Hopenhayn-Rich C., Receveur O., Smith A. H. Vascular effects of chronic arsenic exposure: A review. Epidemiol. Rev. 16:1994;184-208.
17. Engel R. R., Smith A. H. Arsenic in drinking water and mortality from vascular disease: An ecologic analysis in 30 counties in the United States. Arch. Environ. Health. 49:1994;418-427.
18. Finco T. S., Westwick J. K., Norris J. L., Beg A. A., Der C. J., Baldwin A. S. Jr. Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation. J. Biol. Chem. 272:1997;24113-24116.
19. Finkel T. Oxygen radicals and signaling. Curr. Opin. Cell Biol. 10:1998;248-253.
20. Fujita T., Nolan G. P., Liou H. C., Scott M. L., Baltimore D. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes Dev. 7:1993;1354-1363.
21. 2+: Studies with phenylarsine oxide in thyroid plasma membrane. Biochem. J. 321:1997;383-388.
22. Griendling K. K., Ushio-Fukai M. Redox control of vascular smooth muscle proliferation. J. Lab. Clin. Med. 132:1998;9-15.
23. Hei T. K., Liu S. X., Waldren C. Mutagenicity of arsenic in mammalian cells: Role of reactive oxygen species. Proc. Natl. Acad. Sci. USA. 95:1998;8103-8107.
24. Imbert V., Rupec R. A., Livolsi A., Pahl H. L., Traenckner E. B., Mueller-Dieckmann C., Farahifar D., Rossi B., Auberger P., Baeuerle P. A., Peyron J. F. Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell. 86:1996;787-798.
25. Iwanaga M., Mori K., Iida T., Urata Y., Matsuo T., Yasunaga A., Shibata S., Kondo T. Nuclear factor kappaB dependent induction of gamma glutamylcysteine synthase by ionizing radiation in T98G human glioblastoma cells. Free Radic. Biol. Med. 24:1998;1256-1268.
26. James P. E., Grinberg O. Y., Swartz H. M. Superoxide production by phagocytosing macrophages in relation to the intracellular distribution of oxygen. J. Leukoc. Biol. 64:1998;78-84.
27. Jha A. N., Noditi M., Nilsson R., Natarajan A. T. Genotoxic effects of sodium arsenite on human cells. Mutat. Res. 284:1992;215-221.
28. Jones S. A., O'Donnell V. B., Wood J. D., Broughton J. P., Hughes E. J., Jones O. T. G. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am. J. Physiol. 271:1996;H1626-H1634.
29. Klemperer N. S., Pickart C. M. Arsenite inhibits two steps in the ubiquitin-dependent proteolytic pathway. J. Biol. Chem. 264:1989;19245-19252.
30. Koenig W. Haemostatic risk factors for cardiovascular diseases. Eur. Heart J. 19:1998;C39-C43.
31. Landry J., Lambert H., Zhou M., Lavoie J. N., Hickey E., Weber L. A., Anderson C. W. Human HSP27 is phosphorylated at serines 78 and 82 by heat shock and mitogen-activated kinases that recognize the same amino acid motif as S6 kinase II. J. Biol. Chem. 267:1992;794-803.
32. Li J., Elberg G., Shechter Y. Phenylarsine oxide and vanadate: Apparent paradox of inhibition of protein phosphotyrosine phosphatases in rat adipocytes. Biochim. Biophys. Acta. 1312:1996;223-230.
33. Lim C. P., Jain N., Cao X. Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1. Oncogene. 16:1998;2915-2926.
34. Liu Y. S., Guyton K. Z., Gorospe M., Xu Q. B., Lee J. C., Holbrook N. J. Differential activation of ERK, JNK/SAPK and P38/CSBP/RK Map kinase family members during the cellular response to arsenite. Free Radic. Biol. Med. 21:1996;771-781.
35. Ludwig S., Hoffmeyer A., Goebeler M., Kilian K., Hafner H., Neufeld B., Han J., Rapp U. R. The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway. J. Biol. Chem. 273:1998;1917-1922.
36. Lynn S., Shiung J.-N., Gurr J. R., Jan K. Y. Arsenite stimulates poly(ADP-ribosylation) by generation of nitric oxide. Free Radic. Biol. Med. 24:1998;442-449.
37. Montesano R., Pepper M. S., Belin D., Vassalli J.-D., Orci L. Induction of angiogenesis in vitro by vanadate, an inhibitor of phosphotyrosine phosphatases. J. Cell Physiol. 134:1988;460-466.
38. Morooka T., Nishida E. Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J. Biol. Chem. 273:1998;24285-24288.
39. Noll G., Luscher T. F. The endothelium in acute coronary syndromes. Eur. Heart J. 19:1998;C30-C38.
40. Ochi T. Arsenic compound-induced increases in glutathione levels in cultured Chinese hamster V79 cells and mechanisms associated with changes in g-glutamylcysteine synthase activity, cystine uptake and utilization of cysteine. Arch. Toxicol. 71:1997;730-740.
41. Pagano P. J., Clark J. K., Cifuentes-Pagano M. E., Clark S. M., Callis G. M., Quinn M. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc. Natl. Acad. Sci. USA. 94:1997;14483-14488.
42. Penn A. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/1. Mutational events in the etiology of arteriosclerotic plaques. Mutat. Res. 239:1990;149-162.
43. Robaye B., Hepburn A., Lecocq R., Fiers W., Boeynaems J. M., Dumont J. E. Tumor necrosis factor-alpha induces the phosphorylation of 28 kDa stress proteins in endothelial cells: Possible role in protection against cytotoxicity? Biochem. Biophys. Res. Commun. 163:1989;301-308.
44. Sjogren B. Occupational exposure to dust: Inflammation and ischaemic heart disease. Occup. Environ. Med. 54:1997;466-469.
45. Tseng C. H., Chong C. K., Chen C. J., Tai T. Y. Lipid profile and peripheral vascular disease in arseniasis - Hyperendemic villages in Taiwan. Angiology. 48:1997;321-335.
46. Ushio-Fukai M., Alexander R. W., Akers M., Griendling K. K. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J. Biol. Chem. 273:1998;15022-15029.
47. Veillette A., Dumont S., Fournel M. Conserved cysteine residues are critical for the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck. J. Biol. Chem. 268:1993;17547-17553.
48. Wang C. Y., Mayo M. W., Korneluk R. G., Goeddel D. V., Baldwin A. S. Jr. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 281:1998;1680-1683.
49. Wang X., Flynn A., Waskiewicz A. J., Webb B. L., Vries R. G., Baines I. A., Cooper J. A., Proud C. G. The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways. J. Biol. Chem. 273:1998;9373-9377.
50. Wesselborg S., Bauer M. K. A., Vogt M., Schmitz M. L., Schulze-Osthoff K. Activation of transcription factor NF-kappaB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways. J. Biol. Chem. 272:1997;12422-12429.
51. Wu H. L., Yang W. H., Wang M. Y., Shi G. Y. Impaired fibrinolysis in patients with Blackfoot disease. Thromb. Res. 72:1993;211-218.